Based on topics presented at the Annual Japanese (Quantitative) Structure-Activity Relationship Symposium and the Biennial China-Japan Drug Design and Development conference, the topics in this volume cover almost every procedure and subdiscipline in the SAR discipline. They are categorized in three
Qsar and Drug Design: New Developments and Applications
β Scribed by Toshio Fujita (Eds.)
- Publisher
- Elsevier Science Pub Co
- Year
- 1995
- Tongue
- English
- Leaves
- 483
- Series
- Pharmacochemistry Library 23
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
Based on topics presented at the Annual Japanese (Quantitative) Structure-Activity Relationship Symposium and the Biennial China-Japan Drug Design and Development conference, the topics in this volume cover almost every procedure and subdiscipline in the SAR discipline. They are categorized in three sections. Section one includes topics illustrating newer methodologies relating to ligand-receptor, molecular graphics and receptor modelling as well as the three-dimensional (Q)SAR examples with the active analogue approach and the comparative molecular field analysis. In section 2 the hydrophobicity parameters, log P (1-octano/water) for compound series of medicinal-chemical interest are analyzed physico-organic chemically. Section 3 contains the examples based on the traditional Hansch QSAR approach. A variety of methodologies and procedures are presented in this single volume, along with their methodological philosophies
β¦ Table of Contents
Content:
Preface
Pages IX-X
Toshio Fujita
List of contributors
Page XI
Rational approaches to computer drug design based on drug-receptor interactions Original Research Article
Pages 3-48
Akiko Itai, Nobuo Tomioka, Yuichi Kato
Drug design based on receptor modeling using a system Π²ΠΡBIOCES [E]Π²ΠΡ Original Research Article
Pages 49-81
Kenji Akahane, Hideaki Umeyama
Mechanisms of the selective inhibition of thrombin, factor xa, plasmin and trypsin Original Research Article
Pages 83-95
Takao Matsuzaki, Hideaki Umeyama, Ryoji Kikumoto
Three-dimensional structure-activity relationships and receptor mapping of quinolone antibacterials Original Research Article
Pages 97-124
Hiroshi Koga, Masateru Ohta
Classical and three-dimensional quantitative structure-activity analyses of steroid hormones: Structure-receptor binding patterns of anti-hormonal drug candidates Original Research Article
Pages 125-150
Masumi Yamakawa, Kiyoshi Ezumi, Ken'ichi Takeda, Tetsuro Suzuki, Isao Horibe, Goro Kato, Toshio Fujita
Analysis and prediction of 1-octanol/water partition coefficients of substituted diazines with substituent and structural parameters Original Research Article
Pages 153-183
Chisako Yamagami, Narao Takao, Toshio Fujita
Hydrophobicities of di-to pentapeptides having unionizable side chains and correlation with substituent and structural parameters Original Research Article
Pages 185-214
Miki Akamatsu, Toshio Fujita
Analysis of amino acid sequence-function relationships in proteins Original Research Article
Pages 215-233
Takaaki Nishioka, Jun'ichi Oda
Background and features of emil, a system for database-aided bioanalogous structural transformation of bioactive compounds Original Research Article
Pages 235-273
Toshio Fujita, Michihiro Adachi, Miki Akamatsu, Masaaki Asao, Harukazu Fukami, Yoshihisa Inoue, Isao Iwataki, Masaru Kido, Hiroshi Koga, Takamitsu Kobayashi, Izumi Kumita, Kenji Makino, Kengo Oda, Akio Ogino, Masateru Ohta, Fumio Sakamoto, Tetsuo Sekiya, Ryo Shimizu, Chiyozo Takayama, Yukio Tada, et al.
Fuzzy adaptive least squares and its use in quantitative structure-activity relationships Original Research Article
Pages 275-296
Ikuo Moriguchi, Shuichi Hirono
Structure-activity relationships in medicinal chemistry: Development of drug candidates from lead compounds Original Research Article
Pages 299-320
Zongru Guo
Chemical modification and structure-activity relationship studies of piperine and its analogs: an example of drug development from folk medicine Original Research Article
Pages 321-339
Ren-Li Li, Shu-Yu Wang
Structural requirements of leukotriene antagonists Original Research Article
Pages 341-367
Hiroshi Terada, Satoru Goto, Hitoshi Hori, Zenei Taira
Quantitative structure-activity relationships of a new class of Ca-antagonistic and ΠΒ±-blocking phenoxyalkylamine derivatives Original Research Article
Pages 369-412
Kazuya Mitani
Applications of quantitative structure-activity relationships to drug design of piperazine derivatives Original Research Article
Pages 413-450
Hiroshi Ohtaka
Quantitative structure-activity studies of neurotoxic acrylamide analogs Original Research Article
Pages 451-480
Kazuo Hashimoto, Hideji Tanii, Akihisa Harada, Toshio Fujita
Subject index
Pages 481-493
π SIMILAR VOLUMES
This book acquaints students and practitioners in the related fields of pharmaceutical sciences, clinical trials, and evidence-based medicine with the necessary study design concepts and statistical practices to allow them to understand how drug developers plan and evaluate their drug development. T
'New Drug Development' acquaints students and practitioners in the related fields of pharmaceutical sciences, clinical trials, and evidence-based medicine with the necessary study design concepts and statistical practices to allow them to understand how drug developers plan and evaluate their drug d
Comprehensive and impeccably edited, <b>Neural Networks in QSAR and Drug Design is the first book to present an all-inclusive coverage of the topic. The book provides a practice-oriented introduction to the different neural network paradigms, allowing the reader to easily understand and reproduce t
<p>The authors introduce the concept of Molecular Quantum Similarity, developed in their laboratory, in a didactic form. The basis of the concept combines quantum theoretical calculations with molecular structure and properties even for large molecules. They give definitions and procedures to comput
Content: Introduction; Part I. Small Molecules, Proteins, Cellular Systems: New Applications of High; Resolution NMR in Drug Discovery and Development; Solid-state NMR in Drug Discovery and Development; Part II. The Whole Organism in Vivo: Increased Sensitivity Using Cryogenic; Radiofrequency Coils: